Skip to main content
FinSpry Logo
FinSpry
GERN logo
GERN
(NASDAQ)
Geron Corporation
$1.37-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Geron (GERN) Stock Price & Financial Analysis

Geron Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.36 - $1.47
52-Week High$2.01
52-Week Low$1.04
Open$1.38
Volume9.53M
Average Volume (3M)13.04M
Market Cap917.04M
Shares Outstanding669.38M
Price to Sales (P/S)4.68
Price to Book (P/B)4.00
EV/EBITDA-28.46
Revenue (TTM)196.12M
Net Income (TTM)-67.31M
Free Cash Flow (TTM)-126.33M
EPS (TTM)$-0.10
Profit Margin-34.32%
Operating Margin-17.89%
Return on Equity (ROE)-29.38%
Debt to Equity1.10
50-Day MA$1.36
200-Day MA$1.39
52-Week Change-9.87%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Geron

What is the current stock price for GERN?

As of the latest trading session, GERN stock trades at $1.37. The 52-week range is $1.04–$2.01, with a day range of $1.36–$1.47.

What is the P/E ratio for GERN?

The P/E ratio (Price-to-Earnings) for GERN is shown in the Key Statistics section. This valuation metric helps compare Geron Corporation to industry peers.

Does GERN pay dividends?

Geron does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for GERN?

Based on 4 analysts, the consensus for GERN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of GERN?

Geron's market capitalization is $917.0M, classifying it as a small-cap company. Geron operates in the Healthcare sector within the Biotechnology industry.